Story perspectives

Kenya Warns of Counterfeit Avastin Threatening Cancer Patients

10/10/2025

Summary

Story summary

The Pharmacy and Poisons Board (PPB) in Kenya warned about counterfeit Avastin (Bevacizumab 100 mg), Batch Number H0573B01, falsely attributed to Roche.
This counterfeit drug poses significant risks to cancer patients, prompting PPB CEO Ahmed Mohamed to announce a crackdown on distributors.
The PPB emphasized legal consequences for violators and urged stakeholders to source medications from licensed suppliers.
The alert follows false claims regarding a blockade of medical imports, which the PPB has denied.

1 of 1

Story summary

The Pharmacy and Poisons Board (PPB) in Kenya warned about counterfeit Avastin (Bevacizumab 100 mg), Batch Number H0573B01, falsely attributed to Roche.
This counterfeit drug poses significant risks to cancer patients, prompting PPB CEO Ahmed Mohamed to announce a crackdown on distributors.
The PPB emphasized legal consequences for violators and urged stakeholders to source medications from licensed suppliers.
The alert follows false claims regarding a blockade of medical imports, which the PPB has denied.